Loading provider…
Loading provider…
Nephrology Physician in San Francisco, CA
NPI: 1003015439Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get M.D. Pietro's Phone Numberphone_androidMobile
Get M.D. Pietro's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2022
NJ State Medical License
2022 - 2027
NY State Medical License
2007 - 2026
CT State Medical License
2022 - 2024

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
New York Presbyterian Hospital (Columbia Campus)
Fellowship • Nephrology
2008 - 2010
Residency • Internal Medicine
2005 - 2008
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 80 | 208 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 77 | 159 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 55 | 57 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 30 | 35 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 24 | 24 |
Increased risk of kidney failure in patients with genetic kidney disorders.
Authors: Andrew Bomback, Michelle Rheault, Krzysztof Kiryluk, Laura Mariani, Afshin Parsa, Lisa Guay-Woodford, Matthias Kretzler, William Smoyer, Bruce Robinson, Ali Gharavi, Jean Hou
Journal: J Clin Invest
Publication Date: 2024-09-03
Use of Bortezomib in Heavy-Chain Deposition Disease: A Report of 3 Cases
Authors: Andrew Bomback, Nelson Leung, Gerald Appel
Publication Date: 2014-07
Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series
Authors: Andrew Bomback, Gerald Appel, Ali Gharavi
Journal: Clin J Am Soc Nephrol
Publication Date: 2018-01-11
Lead Sponsor: Mayo Clinic
Collaborators: Stanford University, University of Alabama at Birmingham, University of Michigan, Columbia University, The Cleveland Clinic, Medical College of Wisconsin, Case Western Reserve University, University Health Network, Toronto, University of Washington, Washington University School of Medicine, University of British Columbia, University of Toronto, University of Mississippi Medical Center, Ohio State University, NYU Langone Health, University of Kansas Medical Center, Sunnybrook Health Sciences Centre, University of Manchester, CHU de Quebec-Universite Laval, Florida International University, University of Arizona, Applied Health Research Centre, Fulk Family Foundation
Intervention / Treatment: DRUG: Rituximab, DRUG: Cyclosporine
Lead Sponsor: Columbia University
Collaborators: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Valsartan, DRUG: Aliskiren
Lead Sponsor: Mayo Clinic
Collaborators: Genentech, Inc., Biogen, Stanford University, Columbia University, Ohio State University, University of North Carolina, Chapel Hill
Intervention / Treatment: DRUG: ACE/ARB, DIETARY_SUPPLEMENT: Omega-3 Fatty Acid Fish Oil Supplement, DRUG: Intravenous Rituximab